John Glod
About
John Glod is a scholar working on Genetics, Oncology and Molecular Biology.
According to data from OpenAlex, John Glod has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 26 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in John Glod's work include Neuroblastoma Research and Treatments (16 papers), Sarcoma Diagnosis and Treatment (15 papers) and Glioma Diagnosis and Treatment (14 papers). John Glod is often cited by papers focused on Neuroblastoma Research and Treatments (16 papers), Sarcoma Diagnosis and Treatment (15 papers) and Glioma Diagnosis and Treatment (14 papers). John Glod collaborates with scholars based in United States, Canada and United Kingdom. John Glod's co-authors include Debabrata Banerjee, Pravin J. Mishra, Prasun Mishra, Daniel Medina, Jill P. Mesirov, Gabriela Alexe, Rita Humeniuk, Hui Gao, Sonia C. Picinich and Kevin Anton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
John Glod
84 papers receiving 3.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| John Glod United States | 25 | 1.4k | 1.3k | 1.1k | 701 | 464 | 86 | 3.3k | ||
| Venkata Lokesh Battula United States | 21 | 1.4k 1.0× | 1.0k 0.8× | 1.3k 1.1× | 573 0.8× | 236 0.5× | 60 | 3.0k | ||
| Giulia Grisendi Italy | 31 | 1.4k 1.0× | 824 0.6× | 976 0.8× | 538 0.8× | 262 0.6× | 74 | 2.9k | ||
| Markus Weiler Germany | 31 | 1.4k 1.0× | 663 0.5× | 1.2k 1.1× | 534 0.8× | 321 0.7× | 91 | 3.3k | ||
| Yu Yao China | 33 | 1.1k 0.8× | 893 0.7× | 1.1k 1.0× | 772 1.1× | 563 1.2× | 112 | 3.0k | ||
| Tonia Cenci Italy | 25 | 1.3k 0.9× | 1.0k 0.8× | 918 0.8× | 803 1.1× | 331 0.7× | 70 | 2.8k | ||
| Brett M. Hall United States | 22 | 2.0k 1.5× | 2.1k 1.6× | 1.3k 1.1× | 1.0k 1.5× | 380 0.8× | 43 | 4.7k | ||
| Naoki Shinojima Japan | 26 | 1.3k 0.9× | 682 0.5× | 1.3k 1.1× | 602 0.9× | 283 0.6× | 80 | 3.0k | ||
| Mark E. Kleinman United States | 16 | 1.6k 1.2× | 702 0.5× | 685 0.6× | 733 1.0× | 221 0.5× | 31 | 3.3k | ||
| Helen Poppleton United States | 18 | 1.9k 1.4× | 1.6k 1.2× | 1.2k 1.0× | 907 1.3× | 307 0.7× | 23 | 3.6k | ||
| Joy Gumin United States | 28 | 1.9k 1.4× | 1.2k 0.9× | 1.5k 1.3× | 1.0k 1.5× | 255 0.5× | 74 | 3.7k |
Countries citing papers authored by John Glod
Since
Specialization
Citations
This map shows the geographic impact of John Glod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Glod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Glod more than expected).
Fields of papers citing papers by John Glod
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by John Glod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Glod. The network helps show where John Glod may publish in the future.
Co-authorship network of co-authors of John Glod
This figure shows the co-authorship network connecting the top 25 collaborators of John Glod. A scholar is included among the top collaborators of John Glod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Glod. John Glod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alkaissi, Hussam, Sriram Gubbi, Alberto S. Pappo, et al.. (2025). Belzutifan for HIF2A-Related Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data. Endocrine Practice. 32(2). 201–205.
2.
Grohar, Patrick J., Karla V. Ballman, Leo Mascarenhas, et al.. (2024). SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).. Journal of Clinical Oncology. 42(16_suppl). 11508–11508.
3.
Monje, Michelle, Tabitha Cooney, John Glod, et al.. (2023). Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-Oncology. 25(12). 2262–2272.
4.
Lazow, Margot, Adam Lane, Maryam Fouladi, et al.. (2022). Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro-Oncology. 24(9). 1598–1608.
5.
Floros, Konstantinos V., Jinyang Cai, Sheeba Jacob, et al.. (2021). MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis. Cancer Research. 81(7). 1896–1908.
6.
Glod, John, Miki Kasai, Joanne Derdak, et al.. (2020). Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas. Clinical Cancer Research. 26(23). 6112–6121.
7.
Cohen, Julia W., Brigitte C. Widemann, Joanne Derdak, et al.. (2019). Cediranib phase‐II study in children with metastatic alveolar soft‐part sarcoma (ASPS). Pediatric Blood & Cancer. 66(12). e27987–e27987.
8.
Akshintala, Srivandana, et al.. (2018). Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years. The Journal of Pediatrics. 203. 447–449.
9.
Akshintala, Srivandana, Jaydira Del Rivero, Brigitte C. Widemann, et al.. (2018). Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B. The Journal of Clinical Endocrinology & Metabolism. 104(1). 7–12.
10.
Rivero, Jaydira Del, Fernanda I. Arnaldez, Ramaprasad Srinivasan, et al.. (2018). A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (guadecitabine), in children and adults with wild type GIST, pheochromocytoma and paraganglioma associated with succinate dehydrogenase deficiency and HLRCC-associated kidney cancer.. Journal of Clinical Oncology. 36(15_suppl). TPS2608–TPS2608.
11.
Kraft, Ira L., Srivandana Akshintala, Haiyan Lei, et al.. (2017). Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clinical Cancer Research. 24(4). 753–765.
12.
Apolo, Andrea B., Mohammadhadi Bagheri, Jason Levine, et al.. (2017). ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases. Journal of Digital Imaging. 30(3). 275–286.
13.
Mackall, Crystal L., Sandra P. D’Angelo, Stephan A. Grupp, et al.. (2016). Open label non-randomized multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259 SPEAR T-cellsTM in HLA-A*02+ patients with synovial sarcoma (NCT01343043). Annals of Oncology. 27. vi368–vi368.
14.
Medina, Daniel, Lauri Goodell, John Glod, et al.. (2012). Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor B pathways. Haematologica. 97(8). 1255–1263.
15.
Rattigan, Yanique, Brijesh B. Patel, Ellen Ackerstaff, et al.. (2011). Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Experimental Cell Research. 318(4). 326–335.
16.
Rattigan, Yanique, Ellen Ackerstaff, Jason A. Koutcher, et al.. (2011). P1-03-03: Adaptive Exploitation of Stromal Cell Metabolism by Tumor Cells.. Cancer Research. 71(24_Supplement). P1–3.
17.
Mishra, Pravin J., Prasun Mishra, Rita Humeniuk, et al.. (2008). Carcinoma-Associated Fibroblast–Like Differentiation of Human Mesenchymal Stem Cells. Cancer Research. 68(11). 4331–4339.
18.
Banerjee, Debabrata, John Glod, & Arnold B. Rabson. (2007). The Raz mTaz of Human Mesenchymal Stem Cells. Stem Cells and Development. 16(5). 691–694.
19.
Kamen, Barton A., John Glod, & Peter D. Cole. (2006). Metronomic Therapy From a Pharmacologist??s View. Journal of Pediatric Hematology/Oncology. 28(6). 325–327.
20.
Menon, Lata G., Sonia C. Picinich, Rajeth Koneru, et al.. (2006). Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells. Stem Cells. 25(2). 520–528.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Venkata Lokesh Battula Breakdown of academic impact, for papers by Giulia Grisendi Breakdown of academic impact, for papers by Markus Weiler Breakdown of academic impact, for papers by Yu Yao Breakdown of academic impact, for papers by Tonia Cenci Breakdown of academic impact, for papers by Brett M. Hall Breakdown of academic impact, for papers by Naoki Shinojima Breakdown of academic impact, for papers by Mark E. Kleinman Breakdown of academic impact, for papers by Helen Poppleton Breakdown of academic impact, for papers by Joy Gumin